Pressure for development of more efficient battery chemistry in electric vehicle fleets is now greater than ever, prompting greater collaboration between major original equipment manufacturers (“OEMs”), such as Ford, Chrysler and GM, and battery component suppliers. Collaboration within the auto industry may often provide a measure of security against competitors.
But to all OEMS and well-funded startups, take fair warning! When such collaboration takes the form of licensing arrangements to jointly invent a new concept to a commercially satisfactory stage of development, taking the extra time and due diligence to review the terminology in the agreement may save your patents and your sanity, especially if the agreement contains language regarding bestowing rights based on actual reduction to practice of the idea by either party. In such cases, identifying whether one party - prior to the agreement - already achieved an actual reduction to practice of the core concept could be fundamental to your business.
For starters, reduction of an idea to practice may be actual, in that the inventor may build a prototype and test it to confirm it works for its intended purpose. On the other hand, a reduction to practice may be constructive if a patent application is filed for the claimed invention.
After the America Invents Act (AIA) changed U.S. patent law to a “first inventor to file” system on March 16, 2013, when and whether an inventor actually reduced an invention to practice became almost irrelevant. U.S. patent law was no longer a “first inventor to invent” system; the emphasis would now focus upon which application was filed first.
But a recent Opinion by the U.S. Court of Appeals for the Federal Circuit on December 3, 2021 demonstrates a debacle scenario where an actual reduction to practice analysis becomes highly pertinent. Ideal Innovations, Inc. v. United States shows the importance of understanding exactly when there has been an actual reduction to practice for an invention. The case centers on a 2007 licensing agreement between Ideal Innovations, Inc. (“I-3”) and the U.S. Army, and whether the licensing agreement includes the right to practice US Pat. No 8,365,648, and US Pat. No. 8,651,008 directed to the need for “improved armored vehicles that could protect occupants from armor piercing munitions.”
In Ideal Innovations, the concept of actual reduction to practice became material because of the 2007 licensing agreement between I-3 and the U.S. Army providing for the mutual license to practice all inventions “Made” under the agreement. Specifically, the agreement defined “Made” as “the conception or first actual reduction to practice” of an invention arising under the agreement.
So based on the language of their license agreement, I-3 and the U.S. Army had unwittingly paved their way toward a post-AIA actual reduction to practice analysis. Notably, I-3’s ‘648 and ‘008 patents both claim priority to US Pat. No. 7,401,540, filed in 2006 (before the 2007 licensing agreement), but the 2007 licensing agreement had effectively rendered such a priority argument impertinent. Only arguments showing I-3 had actually reduced its invention to practice during or before the 2007 licensing agreement would enable I-3 to keep its patents.
Emerging auto manufacturers and startup suppliers, alike, should be careful when entering licensing agreements providing mutual rights to practice inventions created in performance of work under such agreements. Parties to these agreements are well advised to take note, as the Court did, that under U.S. patent law, once an invention has been conceived, an actual reduction to practice may be achieved when “an inventor (1) constructs an embodiment or performs a process that meets all the limitations of the claimed invention, and (2) determines that the invention would work for its intended purpose.”
Put another way, auto manufacturers and suppliers should consider whether any of their own ideas may have already been actually reduced to practice as inventions before entering a mutual license agreement toward development of a more elaborate, commercialized product.
In this case, I-3 asserted that it had made an actual reduction to practice of the invention for the armored vehicles in 2006, prior to entry into the license agreement with the U.S. Army. In particular, I-3 had previously tested samples of the metal to be used for the armored vehicles in 2006 by conducting test firing of explosively formed projectiles at the sample metals. The tests revealed that the metal successfully withstood the firing, so that there was arguably an actual reduction to practice of the invention by I-3 in 2006, prior to entry into the license agreement.
Despite the Government’s assertion that the testing was insufficient because it was merely conducted on the metal samples of the armor, itself, rather than on a fully assembled vehicle including the armor, the Court cited to prior caselaw noting that “reduction to practice does not require that the invention, when tested, be in a commercially satisfactory stage of development.”
Indeed, I-3 testified that its own testing of just the sample armor alone in 2006, apart from a fully assembled vehicle, “proved the armor could withstand attacks from [explosively formed projectiles], and it was easy to calculate whether a commercially available vehicle chassis—with a known weight capacity—could be mobile while supporting the weight of the armor.”
In remanding the case back to the Court of Federal Claims, the Court of Appeals determined that the lower court’s grant of summary judgment was improper because there was a genuine issue of material fact as to whether a person of ordinary skill in the art would have known based on the testing of the sample metal portions of armor that the invention would work for its intended purpose.
The stakes of the forthcoming proceedings will be high for I-3, to say the least. I-3’s right to exclusively practice the subject matter of its patents to a “Highly survivable urban utility vehicle (HSUUV)” will depend on the ensuing actual reduction to practice analysis by the Court of Federal Claims. The unintended consequence of the parties’ entry into the 2007 licensing accord for mutual practice of all inventions “Made” in performance of work under their agreement remains to be seen.
Regardless of whether a party to a licensing agreement is a startup automaker, battery manufacturer, or supplier, collaboration through such development agreements may necessarily entail retaining the specific technical expertise of outside counsel for dealing with patent matters, particularly where a question of fact may arise relative to when and whether a concept has actually been reduced to practice. Likewise, a central purpose of retaining counsel may center on proactively reviewing licensing agreements for certain language and terminology that may pose high risk to the longevity of an IP portfolio. These are just a few of the considerations.
In the meantime, we now wait to see how I-3 and the Government fare in their license agreement, as the case unfolds before the Court of Federal Claims this year. Stay tuned.
- Associate
John’s practice focuses on domestic and international patent prosecution, intellectual property litigation and due diligence. He also manages information disclosure requirements to ensure compliance with USPTO ...
Subscribe
Recent Posts
- Artificial Ingenuity: Is Generative AI the New 'Person of Ordinary Skill' in Patent Law?
- The Expiration of the After Final Consideration Pilot Program 2.0 (AFCP 2.0)
- Patently Unclear: Why Result-Oriented Claims Don’t Make the Cut Under 35 U.S.C. § 101
- Make Your Invention The Priority, What Track-1 Can Do For You!
- Navigating Final Rejections in Patent Prosecution: AFCP 2.0 vs. 37 CFR § 1.116
- A Clear POV on Patent Eligibility Under 35 U.S.C. 101: Contour’s Claims Zoom Back Into Focus in Contour v. GoPro
- Understanding the Recent Federal Circuit Decision in Broadband iTV, Inc. v. Amazon.com, Inc. on Patent Ineligibility
- Federal Circuit Clarifies Obviousness-Type Double Patenting in Allergan v. MSN Laboratories: The Impact of Patent Term Adjustments on First-Filed Patents
- The Risks and Rewards of Using Open Source Software
- Don't Let Your Trade Secrets Walk Out the Door With Your Employees: Patent Them!
Archives
- November 2024
- September 2024
- August 2024
- June 2024
- May 2024
- April 2024
- February 2024
- January 2024
- December 2023
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- October 2022
- August 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- November 2019
- October 2019
- September 2019
- June 2019
- April 2019
- February 2019
- January 2019
- October 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- August 2017
- July 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017